MLND - Millendo Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7677
Avg. Estimate-0.81-0.81-3.19-3.02
Low Estimate-0.94-1.01-3.32-3.33
High Estimate-0.66-0.68-3.01-2.44
Year Ago EPS-0.82-0.78-1.17-3.19
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6466
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.86-0.7-0.81-0.83
EPS Actual-0.82-0.78-0.74-0.87
Difference0.04-0.080.07-0.04
Surprise %4.70%-11.40%8.60%-4.80%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.81-0.81-3.19-3.02
7 Days Ago-0.81-0.81-3.19-3.02
30 Days Ago-0.83-0.83-3.21-3.02
60 Days Ago-0.9-0.91-3.29-3.18
90 Days Ago-0.92-0.92-3.3-3.25
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMLNDIndustrySectorS&P 500
Current Qtr.1.20%N/AN/A-0.00
Next Qtr.-3.80%N/AN/A0.07
Current Year-172.60%N/AN/A0.01
Next Year5.30%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A